ISOLF

Healthcare Drug Manufacturers - Specialty & Generic

Isodiol International Inc.

$0.00
-0.00 -0.00% today

Price History

Not enough data

Key Stats

Market Cap
4,913.728
Avg Volume
0
52W High
$0.00
52W Low
$0.00
Div. Yield
0.0%

Valuation

P/B Ratio
-0.02
P/S Ratio
0.00
EV/EBITDA
-0.15
EV/Revenue
0.28

Margins

Gross Margin 18.9%
Operating Margin (64.6%)
Net Margin 0.0%
EBITDA Margin (187.1%)

Growth & Returns

Revenue Growth (YoY)
(85.7%)
Return on Equity
(215.3%)
Return on Assets
(21.9%)

Liquidity & Leverage

Current Ratio
1.17
Quick Ratio
0.52
Total Cash
1.51M
Total Debt
5.85M

About

Isodiol International Inc. engages in the development, marketing, distribution, and sale of hemp-based consumer packaged goods and solutions in Canada and the United States. It develops and manufactures phytoceutical consumer products using pharmaceutical and nutraceutical grade phytochemical compounds. The company offers pharmaceutical grade cannabinoid crystalline isolates derived from exempt parts of the hemp plant, as well as micro-encapsulations and nanotechnology for consumable and topical skin care products. It is also involved in manufacturing and distributing hemp oil and nicotine e-liquids, as well as personal care products; provision of apparel and merchandising solutions; manufactures and sells hemp infused beverages; and supplies pharmaceutical products. The company is headquartered in Vancouver, Canada.

isodiol.com